Investor Event and Presentation
N4 Pharma PLC will present at the ShareSoc Growth Company Seminar on Wednesday, October 8, 2025, at the Leonardo Hotel in Leeds. The event commences with registration opening at 4:30 pm and presentations starting at 5:00 pm. Nigel Theobald, Chief Executive Officer, will discuss the ongoing development of Nuvec® as a delivery system for RNA therapeutics. A link to N4 Pharma's presentation will be available on the company website after the event; however, no new material information will be disclosed.
Select text to share a quote on X · sign in to keep highlights & notes in your THAT notes
N4 Pharma plc (AIM: N4P), the UK biotech developing Nuvec®, its proprietary gene delivery system to enable advanced therapies for cancer and other diseases, is pleased to announce that the Company will be presenting at the ShareSoc Growth Company Seminar on Wednesday, 8 October 2025, at the Leonardo Hotel, Brewery Place, Leeds, LS10 1NE. Event registration opens at 4.30 pm and presentations commence at 5.00 pm.
Nigel Theobald, Chief Executive Officer, will be presenting on the Company's ongoing development of Nuvec® as a delivery system for RNA therapeutics.
For further information on the ShareSoc Growth Company Seminar and registration, please visit the event website: https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-person-event-leeds/
A link to N4 Pharma's presentation will be made available on the Company website following the event. No new material information will be disclosed at this event.
| N4 Pharma plc Nigel Theobald, CEO Luke Cairns, Executive Director Submit your questions directly to the management team via the N4 Pharma Investor Hub | Via N4 Pharma Investor Hub: investors.n4pharma.com https://n4pharma.com/link/eY2Bqr . |
| SP Angel Corporate Finance LLP Nominated Adviser and Joint Broker Matthew Johnson/Jen Clarke (Corporate Finance) Vadim Alexandre/Abigail Wayne/Rob Rees (Corporate Broking) | Tel: +44 (0)20 3470 0470 |
| Turner Pope Investments (TPI) Limited Joint Broker Andy Thacker James Pope | Tel: +44 (0)20 3657 0050 |
| Northstar Communications Limited Investor Relations Sarah Hollins | Tel: +44 (0)113 730 3896 |
About N4 Pharma
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.